首页|TGF-β1、ZEB2在上皮性卵巢癌组织中的表达水平及与临床病理特征、预后的关系

TGF-β1、ZEB2在上皮性卵巢癌组织中的表达水平及与临床病理特征、预后的关系

扫码查看
目的:分析转化生长因子β1(TGF-β1)、E盒结合锌指蛋白 2(ZEB2)在上皮性卵巢癌组织中的表达及与临床病理特征、预后的关系。方法:将 2020 年 1 月—2021 年 12 月于南华大学附属第二医院妇科诊治的 30 例上皮性卵巢癌患者的组织石蜡标本纳入试验组,另将本院妇科同时期收集的 30 例良性卵巢上皮性肿瘤患者的组织石蜡标本纳入对照组。采用SP免疫组化法检测两组TGF-β1、ZEB2 表达水平,比较其阳性表达率。分析不同年龄、病理类型、疾病分期、组织分化程度上皮性卵巢癌患者组织石蜡标本的TGF-β1、ZEB2 阳性表达率。对试验组随访 1 年,分析其预后情况,比较生存患者与死亡患者组织石蜡标本的TGF-β1、ZEB2 阳性表达率;运用logistic回归分析法,分析TGF-β1、ZEB2 阳性表达与上皮性卵巢癌患者预后的相关性。结果:试验组TGF-β1、ZEB2 阳性表达率均高于对照组,差异有统计学意义(P<0。05)。不同年龄、病理类型上皮性卵巢癌患者组织石蜡标本的TGF-β1、ZEB2 阳性表达率比较,差异无统计学意义(P>0。05);不同疾病分期、组织分化程度上皮性卵巢癌患者组织石蜡标本的TGF-β1、ZEB2 阳性表达率比较,差异有统计学意义(P<0。05)。随访 1 年,试验组生存 16 例,死亡 14 例;试验组生存患者组织石蜡标本TGF-β1、ZEB2 阳性表达率低于死亡患者,差异有统计学意义(P<0。05)。logistic分析结果显示,TGF-β1、ZEB2 阳性表达均是影响上皮性卵巢癌患者预后的危险因素。结论:TGF-β1、ZEB2 在上皮性卵巢癌组织中呈高表达水平,且其阳性表达率与疾病分期、组织分化程度之间存在明显的相关性;TGF-β1、ZEB2 阳性表达同时也是影响上皮性卵巢癌患者预后的独立危险因素。
Analysis of the Expression Levels of TGF-β1 and ZEB2 in Epithelial Ovarian Cancer Tissue and Their Relationship with Clinical Pathological Features and Prognosis
Objective:To analyze the expression of transforming growth factor β1(TGF-β1)and E-box binding zinc finger protein 2(ZEB2)in epithelial ovarian cancer tissue and their relationship with clinical pathological features and prognosis.Method:A total of 30 tissue paraffin specimens of epithelial ovarian cancer patients diagnosed and treated in the Gynecology Department of the Second Affiliated Hospital of University of South China from January 2020 to December 2021 were included in the experimental group,and 30 tissue paraffin specimens of benign ovarian epithelial tumors patients collected in the Gynecology Department of our hospital during the same period were included in the control group.The expression levels of TGF-β1 and ZEB2 in the two groups were detected by SP immunohistochemistry,and the positive expression rates were compared.The positive expression rates of TGF-β1 and ZEB2 in tissue paraffin specimens of epithelial ovarian cancer patients with different ages,pathological types,disease stages and tissue differentiation were analyzed.The experimental group was followed up for 1 year,the prognosis was analyzed,and the positive expression rates of TGF-β1 and ZEB2 in tissue paraffin specimens of surviving patients and dead patients were compared.logistic regression analysis was used to analyze the correlation between positive expression of TGF-β1 and ZEB2 and prognosis of patients with epithelial ovarian cancer.Result:The positive expression rates of TGF-β1 and ZEB2 in experimental group were higher than those in control group,and the differences were statistically significant(P<0.05).There were no significant differences in the positive expression rates of TGF-β1 and ZEB2 in tissue paraffin specimens of epithelial ovarian cancer patients of different ages and pathological types(P>0.05).The positive expression rates of TGF-β1 and ZEB2 in tissue paraffin specimens of epithelial ovarian cancer patients with different disease stages and tissue differentiation were compared,and the differences were statistically significant(P<0.05).After 1 year of follow-up,16 patients survived and 14 died.The positive expression rates of TGF-β1 and ZEB2 in tissue paraffin specimens of surviving patients in experimental group were lower than those of dead patients,and the differences were statistically significant(P<0.05).logistic analysis showed that the positive expression of TGF-β1 and ZEB2 were risk factors for the prognosis of epithelial ovarian cancer patients.Conclusion:TGF-β1 and ZEB2 were highly expressed in epithelial ovarian cancer tissues,and their positive expression rates were significantly correlated with disease stage and tissue differentiation degree.The positive expression of TGF-β1 and ZEB2 are independent risk factors for the prognosis of patients with epithelial ovarian cancer.

Epithelial ovarian cancerPositive expressionClinical pathological characteristicsRelevance

刘薇

展开 >

南华大学附属第二医院 湖南 衡阳 421001

上皮性卵巢癌 阳性表达 临床病理特征 相关性

2024

中外医学研究
中国医院管理杂志社

中外医学研究

影响因子:1.149
ISSN:1674-6805
年,卷(期):2024.22(16)